Literature DB >> 3775075

Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist.

W M Wisbeck, E M Becher, A H Russell.   

Abstract

Autopsy and clinical records of 85 patients dying of stomach cancer were reviewed in order to study patterns of recurrence and dissemination. Loco-regional recurrence was observed in 15 of 16 patients who had undergone potentially curative surgical resection, and was the most common form of treatment failure. Peritoneal seeding, seen in 29% of the patients who died without treatment, was the most common manifestation of cancer dissemination (47%), and was associated with shorter average duration of survival. Among patients undergoing potentially curative resection, initial serosal involvement was predictive of subsequent peritoneal recurrence (7/10), whereas only 1 of 6 patients with initially uninvolved serosa developed this pattern of failure. Patients with primary cancers involving the gastro-esophageal junction were more likely to have extra-abdominal spread (9/13, 69%) than patients whose cancers involved more distal portions of the stomach (35/72, 49%). Potential implications for surgical staging, choice of radiation treatment volume, and design of clinical trials are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3775075     DOI: 10.1016/s0167-8140(86)80120-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  16 in total

1.  Clinical outcomes according to primary treatment in gastric cancer patients with peritoneal seeding.

Authors:  Jung Min Bae; Kyoung Joon Yeo; Se Won Kim; Sang Woon Kim; Sun Kyo Song
Journal:  J Gastric Cancer       Date:  2011-09-29       Impact factor: 3.720

2.  The role of adjuvant radiation therapy in nonmetastatic gastric cancer: an evolving paradigm.

Authors:  Sunil Krishnan
Journal:  Gastrointest Cancer Res       Date:  2009-01

Review 3.  Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?

Authors:  Jee Suk Chang; Woong Sub Koom; Youngin Lee; Hong In Yoon; Hyung Sik Lee
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  The result of conversion surgery in gastric cancer patients with peritoneal seeding.

Authors:  Se Won Kim
Journal:  J Gastric Cancer       Date:  2014-12-26       Impact factor: 3.720

5.  Patterns of initial recurrence in completely resected gastric adenocarcinoma.

Authors:  Michael D'Angelica; Mithat Gonen; Murray F Brennan; Alan D Turnbull; Manjit Bains; Martin S Karpeh
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

Review 6.  Adjuvant therapy for gastric cancer: current and future directions.

Authors:  Marcus Foo; Trevor Leong
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

7.  A retrospective study on intensity-modulated radiation therapy combined with chemotherapy after D2 radical surgery for gastric carcinoma.

Authors:  Wenguang Luo; Hongyan Zhang; Yufei Zhao; Lin Wang; Lijun Qi; Jingjing Ran; Lei Liu; Aidong Wu
Journal:  Mol Clin Oncol       Date:  2016-03-07

8.  Liver metastasis in cancer of the stomach and its dependence on the histology of the primary tumor: an autopsy study on 102 cases.

Authors:  W Rhomberg; U Gruber
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

9.  Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.

Authors:  W Yu; I Whang; I Suh; A Averbach; D Chang; P H Sugarbaker
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Localized gastric or gastroesophageal cancer - chemoradiation is a pertinent component of adjuvant treatment for patients at high risk of relapse.

Authors:  Leonard L Gunderson; Matthew D Callister; Dawn E Jaroszewski; Helen J Ross; Mitesh J Borad; Richard J Gray; Louis A Lanza; Kristi L Harold; Barbara A Pockaj; Victor F Trastek
Journal:  Gastrointest Cancer Res       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.